Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance

被引:74
|
作者
Johanesen, Priscilla A. [1 ]
Mackin, Kate E.
Hutton, Melanie L.
Awad, Milena M.
Larcombe, Sarah
Amy, Jacob M.
Lyras, Dena
机构
[1] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
Clostridium difficile; antibiotic-associated diarrhea; microbiome; microbiota; antibiotic resistance; mobile genetic elements; TRANSFERABLE TETRACYCLINE RESISTANCE; CONJUGATIVE TRANSPOSON; CHLORAMPHENICOL RESISTANCE; ENTEROCOCCUS-FAECALIS; TN916-LIKE ELEMENTS; VIRULENCE FACTORS; GENETIC-ANALYSIS; DRUG-RESISTANCE; RISK-FACTORS; DIARRHEA;
D O I
10.3390/genes6041347
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Clostridium difficile is well recognized as the leading cause of antibiotic-associated diarrhea, having a significant impact in both health-care and community settings. Central to predisposition to C. difficile infection is disruption of the gut microbiome by antibiotics. Being a Gram-positive anaerobe, C. difficile is intrinsically resistant to a number of antibiotics. Mobile elements encoding antibiotic resistance determinants have also been characterized in this pathogen. While resistance to antibiotics currently used to treat C. difficile infection has not yet been detected, it may be only a matter of time before this occurs, as has been seen with other bacterial pathogens. This review will discuss C. difficile disease pathogenesis, the impact of antibiotic use on inducing disease susceptibility, and the role of antibiotic resistance and mobile elements in C. difficile epidemiology.
引用
收藏
页码:1347 / 1360
页数:14
相关论文
共 50 条
  • [31] Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation
    Deng, Huimin
    Yang, Siqi
    Zhang, Yucheng
    Qian, Kai
    Zhang, Zhaohui
    Liu, Yangyang
    Wang, Ye
    Bai, Yang
    Fan, Hongying
    Zhao, Xinmei
    Zhi, Fachao
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [32] Clostridium difficile Infection and Candida Colonization of the Gut: Is There a Correlation?
    Raponi, Giammarco
    Visconti, Valeria
    Brunetti, Grazia
    Ghezzi, Maria Cristina
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (11) : 1648 - +
  • [33] Prediction of Clostridium difficile infection based on gut microbial traits in patients with Clostridium difficile colonization
    Dong Yan
    Yan-Di Huang
    Yun-Bo Chen
    Tao Lv
    Chun-Xia Zhu
    Jian-Rong Huang
    Lan-Juan Li
    Hepatobiliary&PancreaticDiseasesInternational, 2021, 20 (03) : 298 - 300
  • [34] Monomicrobial Clostridium difficile bacteraemias and relationship to gut infection
    McGill, F.
    Fawley, W. N.
    Wilcox, M. H.
    JOURNAL OF HOSPITAL INFECTION, 2011, 77 (02) : 170 - 171
  • [35] Clostridium difficile infection:: Antibiotic risk and financial impact
    Weinberg, Ethan
    Quianzon, Eric
    Bangoria, Kamalkumar
    Ferguson, Robert P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S196 - S196
  • [36] Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection
    Sullivan, Karyn M.
    Spooner, Linda M.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 352 - 359
  • [37] Fidaxomicin: A Macrocyclic Antibiotic for the Treatment of Clostridium difficile Infection
    Hardesty, Jennifer S.
    Juang, Paul
    PHARMACOTHERAPY, 2011, 31 (09): : 877 - 886
  • [39] Clostridium difficile infection and antibiotic-associated diarrhoea
    Mullish, Benjamin H.
    Williams, Horace R. T.
    CLINICAL MEDICINE, 2018, 18 (03) : 237 - 241
  • [40] Non-antibiotic therapy for Clostridium difficile infection
    Banerjee, S
    Lamont, JT
    CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (03) : 215 - 219